← Back to Search

Home Telehealth with Video for HIV/AIDS

N/A
Waitlist Available
Led By Thomas P. Giordano, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well home telehealth services work when a video component is added for patients with HIV. The goal is to see if this will help them stay in care, which is crucial for managing their illness.

Who is the study for?
This trial is for adults over 18 with HIV who are patients at the Michael E. DeBakey VA Medical Center in Houston, TX. Participants must speak English and be able to consent to using Video to Home Telehealth services (VVC). Those with significant physical or mental disabilities preventing VVC use, or who are incarcerated, cannot join.
What is being tested?
The study is testing how adding video calls (VVC) to home telehealth services affects the ability of HIV patients to stay engaged in their care. It aims to determine the effectiveness of this technology and how it can be implemented successfully.
What are the potential side effects?
Since this trial involves a non-medical intervention (video calls), there aren't typical medication side effects. However, participants may experience issues related to privacy, technical difficulties, or discomfort with video communication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Constancy retention in care measure
Secondary study objectives
Adherence retention in care measure
Adherence to ART medications
Completed visits for adherence counseling
+1 more
Other study objectives
AUDIT
CD4 cell count
HIV viral load
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VVCExperimental Treatment1 Intervention
Option to receive VA Video Connect (VVC) delivery of HIV care.
Group II: Usual CareActive Control1 Intervention
All HIV care available at MEDVAMC will be delivered as usual.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,501 Total Patients Enrolled
Thomas P. Giordano, MD MPHPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX
Jan Alexandra Lindsay, PhDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX

Media Library

VVC Clinical Trial Eligibility Overview. Trial Name: NCT04055207 — N/A
HIV/AIDS Research Study Groups: VVC, Usual Care
HIV/AIDS Clinical Trial 2023: VVC Highlights & Side Effects. Trial Name: NCT04055207 — N/A
VVC 2023 Treatment Timeline for Medical Study. Trial Name: NCT04055207 — N/A
~83 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top